Test marketing phase for the new business
First written in FY2020-Q2. 1 of 4 entries say "Reframed", first in FY2022. Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022ReframedAnnual report
「The company operates through the business segments of Business-to-Business Exhibition Services, Hybrid Exhibition Services and M&A advisory, as well as Other, and manages its reportable segments and business segments under the same classifications.」
The company reorganized the former New Businesses category, which combined the CareTEX365 and overseas businesses, by establishing Hybrid Exhibition Services as a separate segment and classifying the meal-delivery matching business under Other. - FY2020Full-year revenue, loss and impairment recognizedAnnual report
「As a result, net sales for the fiscal year were ¥4.197 million and the segment loss was ¥21.202 million.」
The new businesses, comprising CareTEX365 and the overseas business, generated full-year net sales of ¥4.197 million and a segment loss of ¥21.202 million, and the company also recorded impairment losses on property, plant and equipment and valuation losses on investments in affiliates. - FY2020-Q3Third-quarter revenue and loss recognizedAnnual report
「During the nine months ended the third quarter, the new business remained at the test-marketing stage, and resources were prioritized for developing the core businesses of business-to-business exhibitions and M&A advisory services. As a result, net sales were ¥2.093 million and the segment loss was ¥21.284 million.」
The new business remained at the test-marketing stage, with net sales of ¥2.093 million and a segment loss of ¥21.284 million recorded for the nine months ended the third quarter. - FY2020-Q2First statedAnnual report
「During the six months ended the second quarter, the new business was still at the test-marketing stage, and resources were prioritized for developing the core businesses of business-to-business exhibitions and M&A advisory services. As a result, net sales were ¥1.111 million and the segment loss was ¥17.896 million.」
The new businesses, comprising CareTEX365 and the overseas business, are currently at the test-marketing stage. For the six months ended the second quarter, net sales were ¥1.111 million and the segment loss was ¥17.896 million.